<DOC>
	<DOC>NCT02607176</DOC>
	<brief_summary>The objective of this study is to evaluate safety and efficacy of Heweizhixie Capsule in patients with diarrhea.</brief_summary>
	<brief_title>Heweizhixie capsuleTherapy on Patients With Diarrhea</brief_title>
	<detailed_description>The objective of this study is to evaluate safety and efficacy of Heweizhixie Capsule in patients with diarrhea.This is a Phase 4 Open Label trial, enroll 2400 patients with diarrhea Primary Outcome Measure:Percent of subjects with treatment Success Secondary Outcome Measures: Number of unformed stools passed per 24 h period Time (hours) from first intake to the last unformed stools Change from baseline of Leeds dyspepsia questionnaire score Percent of subjects with AE.</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<criteria>3 or more unformed stools in 24 hours Male and female subjects between 18 and 80 years old Signed informed consent Subjects with serum ALT more than 5ULN or serum Cr more than 442umol/L Subjects are pregnant now, likely to become pregnant Subjects, who in the opinion of the Investigator, are not suitable candidates for enrollment.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>